Pancreatic Cancer Breakthrough? New Drug Combo Controls Tumour Growth In 90% Of Patients

Pancreatic Cancer Breakthrough? New Drug Combo Controls Tumour Growth In 90% Of Patients

Credit: AI image

Text

Updated Nov 22, 2026 | 09:37 AM IST

SummaryThe combination includes daraxonrasib, an experimental targeted cancer drug, and two chemotherapy medicines, gemcitabine and nab-paclitaxel, designed to treat one of the most deadliest cancers.

End of Article